中文 | English
Return
Total: 140 , 1/14
Show Home Prev Next End page: GO
Author:(Wen-qing CUI)

1.Research progress on indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors

Ting WANG ; Hui WEN ; Hua-qing CUI ; Da-li YIN

Acta Pharmaceutica Sinica 2021;56(3):723-733

2.Research progress of KRAS inhibitors

Yan-zhao XU ; Hui WEN ; Hua-qing CUI

Acta Pharmaceutica Sinica 2021;56(6):1562-1570

3.Anti-tumor effects of a novel cyclophosphamide derivate 9b in vivo and in vitro.

Pu-Mei CUI ; Li SHU ; Fei LIU ; Jun-Qing YANG ; Yang SONG ; Wen-Juan SUN

Acta Pharmaceutica Sinica 2014;49(1):44-49

5.Research progress on the development of human neutrophil elastase inhibitors

Zhong-wei WANG ; Hui WEN ; Yu-chen WANG ; Hua-qing CUI

Acta Pharmaceutica Sinica 2023;58(4):909-918

6.Some Approaches for the Selective Isolation of Rare Actinomycetes

Wei XIAO ; Ming-Gang LI ; Xiao-Long CUI ; Yi-Qing LI ; Meng-Liang WEN ;

Microbiology 1992;0(01):-

8.Construction of tissue engineered porcine corneal stroma with skin fibroblasts

yan-qing, ZHANG ; wen-jie, ZHANG ; xiao-jie, HU ; guang-dong, ZHOU ; lei, CUI ; wei, LIU ; yi-lin, CAO

Journal of Shanghai Jiaotong University(Medical Science) 2006;0(02):-

9.Prospective clinical survey of respiratory failure in neonates from the Children's Hospital of Hebei Province.

Wen-Jing LI ; Cui-Qing LIU ; Li MA

Chinese Journal of Contemporary Pediatrics 2008;10(3):307-310

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 140 , 1/14 Show Home Prev Next End page: GO